Board of Directors

Thestrup
Niels Thestrup (1962)
Chairman of the Board

Member of the Board of Directors of ChemoMetec A/S since October 2021. Re-elected in 2024.
Member of the Audit, Nomination and Remuneration Committees.

Not independent as per the definitions of the corporate governance recommendations of Nasdaq Copenhagen, as the law firm of which Niels Thestrup is a partner provides legal advice to ChemoMetec.

Position

Attorney-at-law (SC), Partner, Kønig Advokater I/S. CEO of Thestrup Holding Advokatanpartsselskab, Thestrup Advokatanpartsselskab, N. Thestrup Holding ApS, Thestrup Ejendomme ApS and Ziegler Holding ApS.

Directorships

Chairman of the boards of directors of Co-Ros Fond, Nova5 Arkitekter a/s, Sani Membranes A/S, Løvbjerggård A/S, KG Holding, Søllerød ApS, Pnn Medical A/S, Pnn Medical US A/S, Pnn Memocore ApS and A/S Erik Thestrup. Member of the boards of directors of MedTech Invest A/S, Ejendomsselskabet Dr. Tværgade 5 A/S, Brancor Futures A/S Brancor Securities A/S.

Areas of expertise

Commercial law, including capital markets law, general corporate governance, economics and international business affairs.

 

Martin Glensbjerg
Martin Glensbjerg (1959)
Deputy Chairman

Member of the Board of Directors of ChemoMetec A/S since October 2013. Re-elected in 2024.
Member of the Board of Directors of ChemoMetec A/S for the period 2001-2010.

Not independent as per the definitions of the corporate governance recommendations of Nasdaq Copenhagen, as Martin Glensbjerg has been a senior employee of ChemoMetec within the past five years.

Position

Senior advisor of ChemoMetec A/S and co-founder of ChemoMetec A/S. CEO of ChemoMetec Holding A/S and HMG Technology ApS.

Directorships

Member of the boards of directors of ChemoMetec Holding A/S, Sani Membranes A/S, Udviklingsselskabet Hovedgaden 148 ApS and Byggeselskabet Danmark A/S.

Areas of expertise

Product development and project management as well as production and business development.

 

Færch
Kristine Færch (1976)
Member of the Board of Directors

Member of the Board of Directors of ChemoMetec A/S since October 2020. Re-elected in 2024.
Chairman of the Nomination Committee and Member of the Audit Committee.

Independent as per the definitions of the corporate governance recommendations of Nasdaq Copenhagen.

Position

Project Director, Data Science, Novo Nordisk A/S.

Areas of expertise

Experience in research and development, broad expertise in biology, and in-depth knowledge of the activities and challenges of the principal customer group that ChemoMetec targets.

 

Hagerup
Betina Hagerup (1961)
Member of the Board of Directors

Member of the Board of Directors of ChemoMetec A/S since October 2021. Re-elected in 2024.
Chairman of the Audit Committee and Member of the Nomination Committee.

Independent as per the definitions of the corporate governance recommendations of Nasdaq Copenhagen.

Position

Professional board member.

Directorships

Chairman of Statens It-råd, Member of the boards of directors of the ATTA, Foundation and Center for Cyberkompetencer

Areas of expertise

Broad knowledge of national and international business affairs, strategic and business development, digitalization, and general management.

 

Peter Reich
Peter Reich (1962)
Member of the Board of Directors

Member of the Board of Directors of ChemoMetec A/S since October 2014. Re-elected in 2024.
Chairman of the Remuneration Committee and Member of the Nomination Committee.

Independent as per the definitions of the corporate governance recommendations of Nasdaq Copenhagen.

Position

Director and co-owner of telecommunications provider DSTNY A/S and CEO of Jore ApS, Soft Invest Holding ApS, Bulltrading ApS, PRE Invest Holding ApS, and Soft Holding ApS.

Directorships

Member of the boards of directors of Leto Leasing P/S and BPM Micro ApS.

Areas of expertise

Strategic and business development, general corporate governance, specifically sales and marketing.